{"mainPropery":{"diseaseId":10556,"diseaseName":"Blastic plasmacytoid dendritic cell","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10556/blastic-plasmacytoid-dendritic-cell","synonyms":["BPDCN","Blastic plasmacytoid dendritic cell neoplasm","CD4+/CD56+ hematodermic neoplasm","Lymphoblastoid variant of NK-cell lymphoma","Blastic NK-cell lymphoma","Monomorphic NK-cell lymphoma"],"synonyms-with-source":[{"name":"BPDCN"},{"name":"Blastic plasmacytoid dendritic cell neoplasm"},{"name":"CD4+/CD56+ hematodermic neoplasm","source":"Orphanet"},{"name":"Lymphoblastoid variant of NK-cell lymphoma","source":"Orphanet"},{"name":"Blastic NK-cell lymphoma","source":"Orphanet"},{"name":"Monomorphic NK-cell lymphoma","source":"OrphaData.Org"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"86870"},{"identifierType":"UMLS","identifierId":"C1301363"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=blastic%5BAll+Fields%5D+AND+(%22dendritic+cells%22%5BMeSH+Terms%5D+OR+(%22dendritic%22%5BAll+Fields%5D+AND+%22cells%22%5BAll+Fields%5D)+OR+%22dendritic+cells%22%5BAll+Fields%5D+OR+(%22plasmacytoid%22%5BAll+Fields%5D+AND+%22dendritic%22%5BAll+Fields%5D+AND+%22cell%22%5BAll+Fields%5D)+OR+%22plasmacytoid+dendritic+cell%22%5BAll+Fields%5D)+AND+(%22neoplasms%22%5BMeSH+Terms%5D+OR+%22neoplasms%22%5BAll+Fields%5D+OR+%22neoplasm%22%5BAll+Fields%5D)' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Blastic plasmacytoid dendritic cell. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=86870' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:86870' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":0,"dateModified":"0001-01-01T00:00:00"},"basicQuestions":[],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[{"productId":752,"genericName":"Tagraxofusp-erzs","tradeName":"Elzonris","tradeLink":"","manufacturer":"","sponsor":"Stemline Therapeutics, Inc.","indication":"December 2018,  tagraxofusp-erzs (Elzonris) is a CD123-directed cytotoxin approved for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older.","drugInformationLink":"","medlinePlusLink":""}],"EncodedName":"Blastic_plasmacytoid_dendritic_cell"}